Buford, Ga. – 27 August 2014 - Theragenics Corporation® has leased a facility in San Jose, Costa Rica, which will primarily manufacture components utilized in its vascular access product line. Theragenics Costa Rica Limitada, a wholly-owned subsidiary will operate the facility, which is expected to be operational by the end of 2014. Bernal Rodriguez has been hired as the Plant Manager and the company expects to hire up to 50 new employees over the next several months.
“The opening of our facility in Costa Rica expands our footprint and provides us with manufacturing capabilities we did not previously have,” stated Frank J. Tarallo, the Company’s Chief Executive Officer. “This will allow us to be closer to our vascular access customers. Costa Rica is a country that understands and supports the medical device industry, and our facility there will deliver the same quality, dedication and service that have been our foundation for years.”
Theragenics Corporation operates two business segments: its surgical products business and its brachytherapy seed business. The surgical products business manufactures and distributes wound closure, vascular access, and specialty needle products.
Source: Theragenics Corporation